Neomorph
Phase 1/2Advancing the science of targeted protein degradation to destroy ‘undruggable’ proteins and cure disease
Founded
2020
Focus
ProteomicsSmall Molecules
About
Advancing the science of targeted protein degradation to destroy ‘undruggable’ proteins and cure disease
Funding History
3Total raised: $334M
Series B$150MThird Rock VenturesJan 15, 2024
Series A$109MNextech InvestOct 15, 2022
Seed$75MVersant VenturesMay 15, 2021
Company Info
TypePrivate
Founded2020
LocationSan Diego, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile